Your browser doesn't support javascript.
loading
A Recalcitrant Case of Senear-Usher Syndrome Treated With Rituximab.
de Vries, Jonathan M; Moody, Patricia; Ojha, Avaneesh; Grise, Alison; Sami, Naveed.
Afiliación
  • de Vries JM; Internal Medicine, University of Central Florida College of Medicine, Orlando, USA.
  • Moody P; Dermatopathology, KorPath, Tampa, USA.
  • Ojha A; Internal Medicine, University of Central Florida College of Medicine, Orlando, USA.
  • Grise A; Internal Medicine, University of Central Florida College of Medicine, Orlando, USA.
  • Sami N; Internal Medicine, University of Central Florida College of Medicine, Orlando, USA.
Cureus ; 15(10): e46910, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37954755
ABSTRACT
A 51-year-old uninsured, otherwise healthy male who works in the fishing industry presented with a two-month history of pruritic scaly plaques on his face, scalp, and trunk and mild photosensitivity. A biopsy of a scalp lesion revealed acantholysis consistent with pemphigus foliaceus. Laboratory testing demonstrated elevated anti-desmoglein 1, positive antinuclear antibodies (ANA and anti-dsDNA), and elevated Sjögren's anti-SS-A antibodies. The patient was diagnosed with pemphigus erythematosus. The patient was not optimally responsive and was unable to discontinue systemic corticosteroids despite a maximum dosage of mycophenolate mofetil of 3000 mg/day. Hence, rituximab was added as a rescue treatment with the rheumatoid arthritis protocol. Three months after starting rituximab, there was a marked improvement in symptoms with complete resolution of cutaneous lesions.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos